In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
Clinical trial NCT04343885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04343885
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-21
- Primary completion
- 2026-03-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.